CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to LLY

Paclitaxel (Taxane)

Phase 3
Eli Lilly and Company (LLY)

Phase 3

Development Phase

0

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

3 competitors in Non-Small-Cell Lung Carcinoma

View Full Landscape
Drug Information

Target Indication

Non-Small-Cell Lung Carcinoma

Clinical Trial

NCT00112294

Last updated: 12/8/2025

Patent & Exclusivity
ActiveRLD

Latest Patent Expiry

Jul 12, 2034(7y 8m)

Patents Listed

14

Application

NDA 021660
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.